{"id":557527,"date":"2026-06-01T17:35:32","date_gmt":"2026-06-01T15:35:32","guid":{"rendered":"https:\/\/medizinonline.com\/?p=557527"},"modified":"2026-06-01T17:42:22","modified_gmt":"2026-06-01T15:42:22","slug":"succes-du-passage-a-un-traitement-anti-cgrp-oral","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/fr\/succes-du-passage-a-un-traitement-anti-cgrp-oral\/","title":{"rendered":"Succ\u00e8s du passage \u00e0 un traitement anti-CGRP oral"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Rapport de cas du Dr m\u00e9d. Christophe Bonvin, H\u00f4pital du Valais Sion, Service de neurologie<sup>1<\/sup><\/strong><br><br><strong>De nombreuses options th\u00e9rapeutiques sont disponibles pour la prophylaxie de la migraine, dont l\u2019efficacit\u00e9 et la tol\u00e9rance individuelles ne peuvent souvent \u00eatre \u00e9valu\u00e9es qu\u2019au fil du temps. Les traitements ciblant le CGRP, incluant les anticorps monoclonaux (AcM anti-CGRP) et les antagonistes du r\u00e9cepteur du CGRP (g\u00e9pants), ont consid\u00e9rablement \u00e9largi le spectre th\u00e9rapeutique.<sup>2,3<\/sup> Bien que les anticorps injectables soient efficaces, les effets ind\u00e9sirables li\u00e9s \u00e0 l\u2019injection peuvent limiter l\u2019adh\u00e9sion au traitement et n\u00e9cessiter un changement de forme d\u2019administration.<sup>4\u20136<\/sup> Le pr\u00e9sent cas d\u00e9crit une patiente atteinte de migraine \u00e9pisodique qui a obtenu une r\u00e9duction durable et bien tol\u00e9r\u00e9e du nombre de jours de migraine, sans effets ind\u00e9sirables, apr\u00e8s le passage d\u2019un AcM anti-CGRP \u00e0 un atog\u00e9pant administr\u00e9 par voie orale (Aquipta<sup>\u00ae<\/sup>).<sup>1,7<\/sup><\/strong><\/p>\n\n\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Fsucces-du-passage-a-un-traitement-anti-cgrp-oral%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Rapport de cas du Dr m\u00e9d. Christophe Bonvin, H\u00f4pital du Valais Sion, Service de neurologie1 De nombreuses options th\u00e9rapeutiques sont disponibles pour la prophylaxie de la migraine, dont l\u2019efficacit\u00e9 et&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Fsucces-du-passage-a-un-traitement-anti-cgrp-oral%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"author":17461,"featured_media":556269,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Contenu sponsoris\u00e9: Exp\u00e9rience clinique avec l\u2019atog\u00e9pant (Aquipta\u00ae)","footnotes":""},"category":[11549,11541,11345,11383,11464],"tags":[],"powerkit_post_featured":[],"class_list":["post-557527","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-fr","category-cases-fr","category-contenu-des-partenaires","category-neurologie-fr","category-pharmacologie-et-toxicologie","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-07-18 03:52:15","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"fr_FR","wpml_translations":[],"_links":{"self":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/557527","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/users\/17461"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/comments?post=557527"}],"version-history":[{"count":3,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/557527\/revisions"}],"predecessor-version":[{"id":557542,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/557527\/revisions\/557542"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media\/556269"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media?parent=557527"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/category?post=557527"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/tags?post=557527"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/powerkit_post_featured?post=557527"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}